NCT07431632

Brief Summary

The main objective of this study is to compare epidural blockade with cryoanalgesia of the intercostal nerves as an analgesic method in the postoperative period of minimally invasive repair of pectus excavatum (MIRPE).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Nov 2024Jan 2028

Study Start

First participant enrolled

November 28, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 22, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 24, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

2.1 years

First QC Date

January 22, 2026

Last Update Submit

February 18, 2026

Conditions

Keywords

cryoanalgesiapectus excavatumfunnel chestpostoperative painMIRPE

Outcome Measures

Primary Outcomes (1)

  • Length of stay (LOS)

    Length of stay (LOS) is measured in days from postoperative day (POD) 0 until discharge from hospital.

    Perioperative/Periprocedural.

Secondary Outcomes (7)

  • Numeric pain scale

    Perioperative/Periprocedural

  • Opioid use

    Perioperative/Periprocedural

  • Postoperative complications

    30 days post-surgery.

  • Readmissions to the emergency room or hospital readmission

    Within 30 days after surgery

  • Frequency of neuropathic pain

    Up to 1 year post-surgery.

  • +2 more secondary outcomes

Study Arms (2)

Intraoperative intercostal cryoanalgesia

EXPERIMENTAL

Intercostal nerve cryoanalgesia with the Cryo-S Painless device from Metrum Cryoflex

Device: Cryotherapy

Thoracic epidural block

ACTIVE COMPARATOR

Thoracic epidural block

Procedure: Epidural

Interventions

Intraoperative intercostal cryoanalgesia from T3 to T7, billateral

Intraoperative intercostal cryoanalgesia
EpiduralPROCEDURE

Thoracic epidural block

Thoracic epidural block

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Having pectus excavatum;
  • Having signed the Informed Consent Form for the study.

You may not qualify if:

  • Age \< 13 years at the time of the procedure;
  • Chronic use of analgesics preoperatively;
  • Pectus carinatum, Poland syndrome, or other chest wall anomalies;
  • Previous pectus excavatum repair by any technique;
  • Previous thoracic surgery;
  • Congenital heart disease;
  • Hemorrhagic dyscrasia;
  • Major anesthetic risk factors or history of previous problems with anesthesia;
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thoracic Surgery Division, Heart Institute (InCor), University of Sao Paulo Medical School

São Paulo, São Paulo, 05403904, Brazil

RECRUITING

MeSH Terms

Conditions

Funnel ChestPain, Postoperative

Interventions

CryotherapyInjections, Epidural

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsInjections, SpinalInjectionsDrug Administration RoutesDrug Therapy

Central Study Contacts

Miguel L Tedde, MD, PhD

CONTACT

Diego Arley G Silva, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 22, 2026

First Posted

February 24, 2026

Study Start

November 28, 2024

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

February 24, 2026

Record last verified: 2026-02

Locations